ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
Dow Jones
38,686.32
1.51%
Brent Oil
81.295
0.00%
Bitcoin
67,638.42
0.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oncocyte Corporation (OCX)

  7. Oncocyte Corporation (OCX) News

OCX

Oncocyte (OCX)

Oncocyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OCX
DateTimeSourceHeadlineSymbolCompany
05/31/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
05/30/20244:47PMGlobeNewswire Inc.Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of MedicineNASDAQ:OCXOncocyte Corporation
05/23/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
05/23/202411:26AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
05/23/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
05/22/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
05/22/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
05/17/20245:11PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:OCXOncocyte Corporation
05/15/20244:05PMGlobeNewswire Inc.Oncocyte Reports First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
05/13/20248:00AMGlobeNewswire Inc.Oncocyte to Announce First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
05/10/20245:31PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCXOncocyte Corporation
05/07/20249:19AMGlobeNewswire Inc.PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics MarketplaceNASDAQ:OCXOncocyte Corporation
04/12/20246:00AMGlobeNewswire Inc.Oncocyte Reports Full Year 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
04/11/20249:46PMGlobeNewswire Inc.Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesNASDAQ:OCXOncocyte Corporation
04/11/20245:30PMGlobeNewswire Inc.Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayNASDAQ:OCXOncocyte Corporation
04/09/20244:05PMGlobeNewswire Inc.Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
01/23/20244:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
01/16/20248:00AMGlobeNewswire Inc.Oncocyte to Present at the Sequire Investor Summit in Puerto RicoNASDAQ:OCXOncocyte Corporation
12/06/20238:00AMGlobeNewswire Inc.Oncocyte Begins FDA Submissions Process for VitaGraft Transplant AssaysNASDAQ:OCXOncocyte Corporation
11/09/20235:19PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
11/09/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
11/09/20237:00AMGlobeNewswire Inc.Oncocyte Reports Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
11/03/20238:30AMGlobeNewswire Inc.Oncocyte to Announce Third Quarter 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
10/12/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
10/10/20234:48PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OCXOncocyte Corporation
10/05/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
09/20/20239:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
08/28/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
08/17/20236:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
08/10/20234:50PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
 Showing the most relevant articles for your search:NASDAQ:OCX

Your Recent History

BIT
UC6THX
Unicredit Bank
EU
ROCAV
Occitanie Domestic bonds...
LSE
83YR
Php Bnd Fin 25
LSE
31HL
Sw.fin.a2b
EU
BFCCD
BFCM Banque Federative C...
HUOB
UFTUSDT
UniLend Finance Token
LSE
56VG
Bank Nova 24
USOTC
EBFI
ECO Bright Future (PK)
USOTC
FDBLD
Friendable (PK)
HITB
BETRBTC
Better Betting
LSE
2004
NYSE
TWO.PRA
Two Harbors Investment Corp.
HITB
CITYBTC
Manchester City Fan Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved